Vikas Gupta

发表

North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: Position on Standards of Care and Areas of Need.

M. Konopleva, H. Kantarjian, A. Lane, 2022, Blood.

Screening for signs of portal hypertension by esophagogastroduodenoscopy in patients with BCR‐ABL negative myeloproliferative neoplasms

E. Atenafu, F. Wong, J. Callum, 2023, American journal of hematology.

Biallelic disruption of DDX41 activity is associated with distinct genomic and immunophenotypic hallmarks in acute leukemia

M. Minden, M. Care, K. Yee, 2023, Frontiers in Oncology.

Venous thromboembolism incidence associated with pegylated asparaginase (ASP) compared to the native L‐ASP: A retrospective analysis with an ASP‐based protocol in adult patients with acute lymphoblastic leukaemia

M. Minden, Steven M. Chan, A. Schimmer, 2023, British journal of haematology.

Vascular Events Associated with Alpha Interferon Therapy

M. Minden, J. Lipton, H. Messner, 2003, Leukemia & lymphoma.

A phase I study of tipifarnib combined with conventional induction and consolidation therapy for previously untreated patients with acute myeloid leukemia aged 60 years and over

B. Leber, M. Minden, M. Moore, 2009, Leukemia.

Prevalence of frailty and its association with clinical outcomes in myeloproliferative neoplasms: a population-based study

M. Cheung, S. Alibhai, N. Liu, 2023, Blood advances.

Impact of Geographical Distance from Quaternary Treatment Center on Clinical Trial Participation, Intensive Induction Chemotherapy, and Outcomes in Patients with Newly Diagnosed Acute Myeloid Leukemia

K. Yee, E. Atenafu, A. Schuh, 2023, Acta Haematologica.

Exclusion of persistent mutations in splicing factor genes and IDH2 improves the prognostic power of NGS-based MRD assessment in acute myeloid leukemia

M. Minden, Steven M. Chan, A. Schimmer, 2023 .

Outcomes of Patients with Accelerated/Blast-Phase Myeloproliferative Neoplasms in the Current Era of Myeloid Therapies

Jacqueline S. Garcia, M. Burkart, J. Cursio, 2022, Blood.